NASDAQ Stock Exchange
Tickers analyzed: 2 829 | Updated: 2019-12-13 | Next Update: 2019-12-16
Today's Case: TG Therapeutics (TGTX)
Bullish vs. Bearish (6 opinions)
Social Sentiment 0.52
TGTX Forecast and Technical Stock Analysis
Buy candidate since 2019-12-09 Gain 8.84% PDF
TG Therapeutics gained 7.50% in the last trading day ( Friday, 13th Dec 2019 ), rising from $9.40 to $10.10 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 13.53% from a day low at $9.50 to a day high of $10.79. The price has been going up and down for this period, and there has been a 23.32% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 2.59 million more shares were traded than the day before. In total, 4.93 million shares bought and sold for approximately $49.75 million.
- 30 day high of the TGTX stock price was $10.79 and low was $7.04.
- 90 day high was $10.79 and low was $4.95.
- 52 week high for TG Therapeutics - $10.79 and low - $3.32.
TG Therapeutics has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $9.60, a level that may pose a second chance to hit a runner. According to fan-theory $11.78 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.
Only positive signals in the chart today. TG Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $8.85 and $7.83. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday December 11, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 68 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $9.42 and $9.28.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, TG Therapeutics finds support just below today's level at $9.42. If this is broken, then the next support from accumulated volume will be at $9.28 and $7.81.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.29 between high and low, or 13.53%. For the last week, the stock has had a daily average volatility of 11.81%.
Our recommended stop-loss: $9.64 (-4.58%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)
11.81 %Average volatility
Very Low Low Medium High Very High
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term period.